To present our outcomes of ventral-onlay buccal mucosa graft (BMG) substitution urethroplasty in treating female urethral stricture (FUS).
Introduction
Female urethral stricture (FUS), although uncommon, has a large impact on quality of life, with urethral pain and recurrent infections causing much misery. BOO in women may be more common than previously believed, occurring in [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] .4% of women presenting with LUTS [1, 2] , with FUS causing BOO and LUTS in 0.32-4.9% of cases [3] [4] [5] . Traditionally FUS has been managed using endoscopic techniques with or without intermittent self-catheterization (ISC). Unfortunately, endoscopic techniques have high recurrence rates [6, 7] . There is a group of women who experience rapid FUS recurrence after dilatation/urethrotomy, despite ISC or in association with inability to perform ISC because of urethral pain. This group of women are candidates for urethroplasty. A number of different techniques have been described for female urethroplasty surgery, using flaps or grafts, with differing approaches, differing donor tissues and differing placement of donor tissue [8] [9] [10] .
We report our experience using the ventral onlay buccal mucosa graft (BMG) substitution urethroplasty technique as a potentially curative operation for FUS.
Patients and Methods
We analysed a prospectively collated database of all women who underwent ventral onlay BMG substitution urethroplasty by a single surgeon in a tertiary referral centre for recurrent refractory urethral stricture from June 2012, and reviewed all patients with maximum urinary flow rate (Q max ), post-void residual urine volume (PVR) data and clinical follow-up at a minimum of 6 months after surgery. A total of 22 cases were identified. All women had a formal history recorded, and underwent clinical examination, free flow study with PVR measurement, and video urodynamics a.k.a. videocystometrogram (VCMG). All strictures were visualized on VCMG and cysto-urethroscopy, with pelvic MRI used to exclude other causes of BOO and sinister urethral pathology in all women. VCMG was performed with a 6-Ch dual-lumen catheter, through which contrast was instilled at a rate of 50 mL/min. Images were recorded with fluoroscopy at every 100 mL of filling and during the voiding phase. Stricture was identified by the presence of urethral ballooning proximal to a portion of urethral narrowing (Fig. 1 ) [11] and urodynamic BOO (defined as detrusor pressure at maximum flow (pDetQ max ) > 2.2 9 maximum flow rate (Q max ) + 5 as per the Solomon-Greenwell pressure-flow nomogram) [12] ). In two cases, voiding was not achieved whilst standing with the pressure lines in, and stricture was subsequently confirmed with cystourethroscopy.
The VCMG was performed to evaluate overall lower urinary tract function, confirm the diagnosis of BOO, demonstrate urethral stricture as the cause of obstruction and determine the site and the length of the urethral stricture. MRI was performed to exclude additional or associated urethral pathology. The use of VCMG and MRI allowed us to more fully counsel women about their possible outcomes after surgery and provided essential surgical planning information.
No patients were lost to follow-up. Two patients were discharged to more local follow-up at 2 years after surgery at their request, but continue to have telephone and flow rate follow-up.
Primary success was defined as absence of recurrent stricture, as defined by normalization of flow rate (rate and pattern) and PVR, and resolution of symptoms. Secondary outcome measures included mean flow rate, mean PVR and development of new-onset stress urinary incontinence (SUI). Follow-up included outpatient medical review at 6 weeks, 6 months, 12 months and annually thereafter for; history, examination, urinary flow rate and PVR. Further specialist investigation with VCMG or cysto-urethrography was performed if indicated at outpatient review (by poor flow rate, abnormal flow rate pattern, raised PVR or recurrence of symptoms). Postoperative complications were recorded based on the Clavien-Dindo classification system [13] .
Data were analysed for stricture recurrence, change in median peak free flow rate (Q max ) and median PVR. Statistical analysis was performed using the Wilcoxon signed rank test, Student's t-test and the Mann-Whitney U-test.
Surgical Technique
The procedure was performed with the patient in standard lithotomy position. The table was placed moderately head down. The WHO surgical safety checklist was completed, ensuring TED stockings and Flowtron boots were applied and prophylactic gentamicin and co-amoxiclav were injected i.v. (if the patient was not allergic). The labia majora were sutured out of the operative field with a 1 silk stitch and a vaginal retractor (Galaxy Vaginal Retractor, June Medical, Marlow, UK) was positioned and secured with elastic hooks. A 6-Ch Fogarty embolectomy catheter was inserted into the urethra and the balloon inflated with 1.25 mL of sterile water. The embolectomy catheter tubing was then clamped with a clip to ensure the balloon remained inflated. The embolectomy catheter was slowly withdrawn past the bladder neck and used to identify the proximal end of the stricture.
Following this, the anterior vaginal wall in the region of the urethra was infiltrated with 5 mL of 0.5% lidocaine with 1:100 000 epinephrine (adrenaline). A midline incision was made in the anterior vaginal wall in the region of the proximal end of the stricture. Once the paraurethral plane was entered the overlying anterior vaginal wall was mobilized bilaterally to allow visualization and access to the ventral aspect of the whole of the urethra from 3 to 9 o'clock. A ventral stricturotomy was made into the urethra at 6 o'clock, and continued through the length of the stricture and 0.5 cm either end of the stricture.
Then, 3/0 stay sutures were placed, incorporating the urethral mucosa, to allow ease of placement of the buccal mucosa patch (Fig. 2) . Sufficient BMG was harvested from the inner cheek to span the length of the stricturotomy and create a 30-mm urethra (Fig. 3) . A 16-Ch silicone catheter was then placed and the BMG patch was sutured to the stricturotomy with continuous 5/0 polyglactin 910 (Vicryl) sutures (Fig. 4) . Where sufficient, the overlying urethral spongiosal tissue was sutured over the patch (four women) supported by the interposition of a Martius labial fat pad flap. A modified Martius labial fat pad was interposed in all women to provide a healthy vascular base for the buccal mucosal free graft, reduce the risk of urethrovaginal fistula development and provide healthy tissue between the reconstructed urethra and the overlying vagina to facilitate any future surgery for subsequent SUI, should it occur. In our hands, this adds 20 min to the procedure and is associated with minimal morbidity and good cosmetic outcomes [14] .
The Martius labial fat pad flap was harvested on its posterior pedicle, tunnelled along the lateral wall of the vagina, and sutured over the BMG patch using 3/0 polyglatin 910 sutures to the adjacent paravaginal fascia (Fig. 5 ). 5/0 mattress quilting sutures were used to fix the fat pad to the graft. The vaginal epithelium was then closed with a continuous 3/0 poliglecaprone 25 (Monocryl) suture, and a small vaginal pack inserted. The labial harvest site was closed over a minivac drain, after careful haemostasis, in layers with 3/0 polyglactin 910 sutures.
Postoperatively, the drain and vaginal pack were removed on day 2 and the patient discharged home when comfortable, to return at 3 weeks for a pericatheter urethrogram and trial of void if healed.
A pericatheter urethrogram is performed by introducing a lubricated 6-Ch infant feeding tube alongside the urethral catheter and advancing it under screening to level with the bladder neck. Water-soluble contrast is then gently injected whilst the feeding tube is withdrawn, until the whole of the urethra is visualized whilst screening in the anteroposterior (AP) and 30°oblique positions.
Results
The median (range) age of the 22 women was 50 (34-72) years. Aetiology of the stricture was difficult to determine in the majority of women. Two had stricture after urethral diverticulum excision (one of whom had a recurrent urethral diverticulum), one had undergone radiotherapy for urethral cancer, one had lichen planus, one had had an obstructive tension-free vaginal tape removed and one had a history of urethral catheterization at the time of childbirth. Seven women reported a history of recurrent UTIs leading up to the diagnosis of their stricture, but whether this was the consequence or cause of their stricture is debatable. A further two gave a history of cervical cautery for cervical intraepithelial neoplasia and seven had no precipitating cause identifiable. The median (range) length of stricture was 2 (0.5-3.5) cm and the median (range) length of stricturotomy was 3 (1.5-4.5) cm (full length). The most proximal extent of the stricture was defined as proximal urethra in six, mid urethra in 11 and distal urethra in five women. The most proximal extent of the stricturotomy was proximal urethra in 13 women, mid urethra in eight women and distal urethra in one woman. Stricture-free survival was achieved in 21/22 (95.5%) women at a median (range) follow-up of 21.5 (6-51) months. Stricture-free survival was determined by absence of symptoms in the presence of normal flow rate (>12 mL/s/s) and flow pattern and residual volume <100 mL. Any woman not meeting these criteria progressed to cystoscopy to exclude a recurrent stricture.
The patient with recurrent stricture had previous simultaneous excision of circumferential urethral diverticulum and two large para-urethral cysts. She had a completely occluded urethra with a distal 1.5 cm urethral stricture at the time of her ventral onlay BMG substitution urethroplasty, and a history of bladder pain syndrome and SUI. She had a postoperative Q max of 6 mL/s with a PVR of 80 mL and restricture was confirmed on cystourethroscopy 25 months after urethroplasty, which showed a distal 0.5-cm meatal level recurrence. She subsequently underwent urethral dilatation and is currently maintained on weekly ISC. Interestingly, she is now pain-free and able to perform ISC without difficulty after her urethroplasty.
We observed that Q max values increased significantly and PVRs reduced significantly after urethroplasty (Table 1) .
Short-and longer-term complication rates were low. No immediate postoperative complications higher than ClavienDindo grade 1 were recorded. One woman developed mild de novo SUI, which settled with conservative measures by 6 months. The woman with the recurrent urethral stricture and pre-existing SUI continued to have SUI.
Concomitant additional findings were found on VCMG in 11 women (50%); detrusor overactivity was found in six women, SUI in four women and recurrent urethral diverticulum in two women (one of whom also had SUI). MRI showed recurrent urethral diverticulum in two women (only one of which was visualized on VCMG) and no evidence of malignancy.
Discussion
The management of urethral stricture in women includes urethral dilatation, urethrotomy, clean ISC and substitution urethroplasty [10, 15] . It is widely accepted that outcomes from urethral dilatation are often only good in the short term [6, 7] and that, for long-term benefits, ISC is required. There is increasing evidence to suggest that urethroplasty may be the 'gold standard' for achieving long-term stricture-free and ISC-free life [3, 6, 10, 15] . Over the years a number of urethroplasty techniques have been described: flap (vaginal [6] , vestibular [16] or pedicled labia minora [8] ); graft (vaginal [17] , labia minora [18] , lingual or BMG [6, 19, 20] ); ventral and dorsal approaches [20, 21] ; and inlay and onlay placements. [22, 23] .
We have summarized the outcomes of all published female urethroplasty series in Table 2 [6, 8, 9, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . The median number of urethroplasty cases in these papers was 8, ranging from 2 to 30 [8, 26] . The paper with 30 cases deals only with meatoplasty for meatal stenosis [26] and several of the other papers detail the outcomes of more than one type of urethroplasty. Reported stricture-free outcomes vary from 50% to 100% at mean follow-ups of 6 to 80.7 months. To our knowledge, this is the largest series detailing the outcomes of one urethroplasty technique reported in the literature to date.
The volume of refractory recurrent FUS disease is low and the techniques used continue to be refined, and this makes it difficult to produce high-quality studies. No consensus currently exists as to which of the substitution urethroplasty techniques offers the optimum outcomes [15] .
The technique of ventral free-graft urethroplasty was first described in 1963 by Devine et al. [34] , who used fullthickness skin graft to repair male urethral strictures. Buccal mucosa is a more successful graft material than skin in male urethroplasty, with success rates of 80.5% compared with 63.6% in penile skin dorsal onlay urethroplasties at 16 years' follow-up [35] .
Buccal mucosa as a substitute for urethral tissue was first described by Humby in 1941 [36] , but only gained widespread popular use in the 1990s. Now, it is the most commonly employed extragenital graft tissue for urethroplasty [37] . Buccal mucosa has been advocated because it has biological and structural properties that make it ideal for grafting into the lower urinary tract [38, 39] as a result of its similarity to the urethral mucosa; it is hairless, designed for moist environments, is impermeable to urine, has antibacterial properties and is elastic. Furthermore, it can be easily harvested with minimal donor site complications [40] . Table 1 Maximum flow rates and post-void residual urine volumes before and a median (range) of 21.5 (6-51) months after ventral onlay buccal mucosa graft urethroplasty.
Before ventral onlay BMG urethroplasty After ventral onlay BMG urethroplasty
Median (range) Q max , mL 7 (3.5-11.2) 18 (5-37)* Median (range) PVR, mL
The theoretical risk to the parotid and mental nerves was not seen in our series, and improved harvesting techniques have reduced the likelihood of these events. A common delayed postoperative symptom reported is that of contracture of the cheek [40] . We do not close our buccal harvest site and have had no donor site morbidity in the present series.
Vulvovaginal atrophy is a common condition associated with post-menopausal decreased oestrogenisation of the vaginal tissues [41] . Vaginal flaps may atrophy with advancing age and cause delayed stricture recurrence. Kowalik et al. [9] compared vaginal flap urethroplasty with dorsal onlay BMG urethroplasty in six and four women, respectively, and found that, at a median follow-up of 43 months for vaginal flap urethroplasty and 24 months for BMG, one third of the women who underwent vaginal flap urethroplasty developed stricture recurrence. No woman undergoing dorsal onlay BMG urethroplasty developed a stricture. These findings were also noted by Blaivas et al. [6] , who reported recurrences in two women undergoing vaginal flap urethroplasty in their series, but none in their BMG urethroplasties. It may be that this difference is a reflection of the longer follow-up available in the vaginal flap urethroplasty group (median 54 months) compared with the BMG group (median 15 months) or that BMG is a better material for female urethroplasty.
Gozzi et al. [21] first described the ventral onlay technique using split-thickness labia minora graft in 2011 and showed its potential for good functional outcomes. The advantages of ventral-onlay grafting include the lower risk of new-onset SUI with ventral urethral incision because of the horseshoe shape of the female urethral sphincter with its ventral deficiency [42] . This was verified in the present study, in which only one woman (4.5%) developed SUI after urethroplasty, which was mild and self-limiting. It may be that our patients also derived additional benefit in terms of continence from the Martius labial fat pad interposition, although there is no evidence to support or gainsay this supposition. To our knowledge, this is the first series describing the technique of a ventral onlay of buccal mucosa for FUS. Limitations of the study include the relatively low overall numbers (although they are large for a female urethroplasty series), the medium-term nature of the follow-up and the lack of validated patient-reported outcomes. There are currently no validated outcome measures for women with urethral stricture, the majority of whom have a combination of urethral pain, irritative and obstructive symptoms [3] ; however, early-to medium-term experience suggests that ventral onlay BMG substitution urethroplasty is a highly efficacious, reproducible urethroplasty technique in the treatment of refractory recurrent urethral stricture in women, with low complication rates.
In conclusion, ventral onlay BMG substitution urethroplasty with martius labial fat pad interposition provided stricturefree outcomes in 21/22 women (95.5%) with refractory recurrent FUS disease at a medium-term median follow-up of 21.5 months. It significantly increased flow rate, significantly reduced PVR and had few short-and long-term side effects.
